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We show that the 4-0x0 analogue of N-acetyl-D-neuraminic acid strongly inhibits N-acetylneuraminate lyase (NeuAc 
aldolase, EC 4.1.3.3) from Clostridum perfringens (Ki = 0.025 mM) and Escherichiu coli (4 = 0.15 mM). In each case the 
inhibition was competitive. 
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1. INTRODUCTION 
NeuAc aldolase is a key enzyme of sialic acid 
metabolism catalyzing the reversible cleavage of N- 
acetylneuraminic acid to pyruvate and ZV- 
acetylmannosamine [1,2]. The enzyme is, in vivo, 
predominantly involved in the catabolic pathway 
[2]. Previous studies indicated that for enzymes in- 
volved in sialic acid metabolism C-4 of NeuAc is a 
crucial area [2-61. Thus, NeuAc aldolase requires 
an equatorially oriented hydroxy group at C-4 
[2,4,7,8]. Synthetic NeuAc analogues promise to 
be a useful tool to influence the activity of this 
aldolase. 4-Deoxy- and 4-epi-NeuAc competitively 
inhibit the enzyme, both analogues being resistant 
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towards cleavage [7,8]. Based on these results we 
have synthesized a sialic acid carrying an 0x0 
group at C-4 as inhibitor of NeuAc aldolase. Addi- 
tionally, the ethyl-a-glycoside of 4-oxo-NeuAc and 
the 4-0~0 analogue of 2,3-dehydro-NeuAc were 
studied for aldolase inhibition. 
2. MATERIALS AND METHODS 
2.1. Materials 
All chemicals used were of analytical grade and were pur- 
chased from Merck (Darmstadt) or Serva (Heidelberg). 
Crystalline N-acetylneuraminic acid was prepared in this 
laboratory. Acetonitrile grade S was obtained from Zinsser 
(Frankfurt). NeuAc aldolase (5.5 U/mg) from Clostridium per- 
fringens was from Sigma (Mtinchen), the respective enzyme 
from Escherichia coli (30 U/mg) and lactate dehydrogenase 
(500 U/mg) being obtained from Boehringer (Mannheim). 
4-Oxo-NeuAc and 2-o-ethyl-4-oxo-NeuAc were synthesized 
from the benzyl- and ethyl-o-glycoside of NeuAc via the 
diphenyl methyl ester of the 8,9-isopropylidene derivative. Ox- 
idation by CrOp/pyridine afforded after removal of the pro- 
tecting groups the respective 4-0~0 analogues [9]. Oxidation of 
2,3-dehydro-NeuAc yielded the 4-0~0 compound. The detailed 
syntheses will be described elsewhere. 
2.2. Methods 
2.2.1. Coupled enzymatic assay 
The assay was performed using lactate dehydrogenase (EC 
1.1.1.27) as coupling enzyme [8]. NeuAc or 4-oxo-NeuAc were 
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tested for cleavage at 5 mM; inhibition was determined at 
5 mM NeuAc in the presence of 0.057, 0.114 or 0.228 mM 
4-oxo-NeuAc. 
2.2.2. NeuAc aldolase assay 
This was performed using a modified Morgan-Elson method 
[8]. The reaction mixture (200 rl) contained 20 rmol 
KH~PO~/KZHPO~ buffer, pH 7.2 (C. perfringens aldolase) or 
pH 7.7 (E. coli aldolase), varying amounts of NeuAc and in- 
hibitor and 20 mU of the respective NeuAc aldolase. The cor- 
responding controls lacked enzyme. The assay was linear with 
time for 20 min in the absence and presence of 0.0125 mM 
4-oxo-NeuAc. Initial rates for the kinetics were determined as 
described above after 7 min incubation at 37°C. 
NeuAc aldolase (C. perfringens) inhibition by 4-oxo-NeuAc 
was studied as follows. Firstly, NeuAc was varied between 1.25 
and 10 mM without inhibitor and in the presence of 0.025 and 
0.05 mM inhibitor; secondly, the inhibitor was varied between 
0.0125 and 0.125 mM at fixed concentrations of NeuAc (2, 5, 
8 mM). Inhibition of NeuAc aldolase (E. co/r) was determined 
by varying the concentration of 4-oxo-NeuAc between 0.1 and 
1.1 mM at fixed concentrations of NeuAc (2, 5, 8 mM). 
Inhibition of C. perfringens aldolase by ti-ethyl-4-oxo- 
NeuAc and 4-oxo-2,3-dehydro-NeuAc was studied as above 
with inhibitor concentrations adapted to the Ki value. 
3. RESULTS 
As expected, 4-oxo-NeuAc was no substrate for 
NeuAc aldolase as determined by the coupled en- 
zymatic assay. However, this analogue proved to 
be a reversible inhibitor of the enzyme. After 
dialysis of an enzyme-inhibitor mixture the activity 
was completely restored. 4-Oxo-NeuAc was stable 
during incubation at pH 7.2 or 7.7 for 15 min as 
monitored by analytical HPLC at 200 nm [lo]. For 
determination of the inhibition pattern and Ki 
value the reaction rate was obtained from the 
amount of N-acetylmannosamine formed using a 
modified Morgan-Elson assay [8]. The results 
agreed with those of studies employing the coupled 
enzymatic assay (see section 2). 
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Fig.1. Initial rate kinetics for inhibition of NeuAc aldolase 
(Clostridium perfringens) by 4-oxo-NeuAc plotted according to 
Dixon. Assays were performed as described in section 2. 
Concentrations of 4-oxo-NeuAc (0.0125-o. 125 mM) were 
varied at fiied concentrations of NeuAc [2.0 mM (M), 
5.0 mM (x-x), 8.0 mM (e )]. Each point represents the 
average of duplicate assays. 
Initial rate data for inhibition of NeuAc aldolase for NeuAc calculated from Hanes plots being 
(C. perfringens) by 4-oxo-NeuAc were plotted ac- 3.5 mM in accordance with [l]. The Ki value of C. 
cording to Lineweaver-Burk and Dixon [l 11. A perfringens aldolase for 2cu-ethyl-4-oxo-NeuAc 
competitive inhibition pattern was obtained in determined from Dixon plots (9.5 mM) was high 
both plots. The Ki value of this enzyme was compared to that for 4-oxo-NeuAc. Whereas 
0.025 mM as obtained from Dixon plots (fig.l), 2,3-dehydro-NeuAc did not inhibit this enzyme, 
and 0.020 mM as calculated from Lineweaver- the corresponding 4-0~0 analogue showed a Ki 
Burk plots. The K,,, value for NeuAc determined value of about 1 mM (Lineweaver-Burk plots). An 
from Hanes plots [l l] was 3.75 mM, in agreement identical kinetic value was obtained from Dixon 
with that obtained by using the coupled enzymatic plots between 0.188 and 2.25 mM 4-oxo-2,3-dehy- 
assay [1,8,12]. Dixon plots with E. coli aldolase dro-NeuAc. At higher concentrations of inhibitor 
demonstrated aKi value of 0.15 mM, the K, value the plot changed to a non-linear pattern. 
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Fig.2. Structure of 4-oxo-NeuAc. 
4. DISCUSSION 
The action of NeuAc aldolase depends on an un- 
substituted hydroxy group at C-4 of sialic acid. 
Based on the structure of NeuAc only two com- 
pounds are known so far to be competitive in- 
hibitors of the enzyme. We have described 
inhibition by 4-deoxy-NeuAc [4], and this has been 
confirmed recently [7]. The respective Ki values are 
1.25 mM (Morgan-Elson assay [8]; unpublished) 
and 0.93 mM (coupled enzymatic assay [7]). 4-epi- 
NeuAc was found to have a Ki value of 2.3 mM as 
determined by two independent methods [S], 
whereas a IO-fold lower Ki value was observed with 
the same analogue synthesized via a different route 
[7]. The large difference in kinetic data is as yet 
unexplained. 
4-Oxo-NeuAc represents the most potent in- 
hibitor reported as yet, with a Ki value of 
0.025 mM for C. perfringens NeuAc aldolase 
(fig.2). Considering the reaction mechanism pro- 
posed for this enzyme [ 12-141 the 0x0 group at 
C-4, instead of that at C-2, may form a Schiff base 
with lysine at the active site. Alternatively, an enol 
may arise at C-4 which would interact with the 
catalytically important histidine. All sialic acid 
analogues studied in this paper contain an 0x0 
group at C-4 as the prominent structural element. 
However, the analogues differ in ease of access to 
the active site of the aldolase, as indicated by the 
different Ki values. In contrast to unsubstituted 
4-oxo-NeuAc, the ethyl glycoside cannot form an 
open chain. Although this also applies to 
4-oxo-2,3-dehydro-NeuAc, in this case the double 
bond flattens the pyranose ring and may thus in- 
duce a more favourable conformation compared 
to the ethyl a-glycoside. 
It remains to be seen whether 4-oxo-NeuAc can 
be employed to block aldolase activity in a mam- 
malian system. It is noteworthy that this analogue 
is neither a substrate nor an inhibitor for CMP- 
sialic acid synthase, and that sialidases are not in- 
hibited (unpublished). 
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